EO decisions and CED recommendations
Information on drug funding decisions based on Executive Officer (EO) decisions and Committee to Evaluate Drugs (CED) recommendations. This information is intended for medical professionals and drug manufacturers.
Use the data API
Visualize data
Use the Data Visualizer below to display this dataset as a table, graph or map.
Report an issue with this data
Submit a report if you are experiencing issues with the data resources in this dataset.
Data dictionary
Column | Type | Description |
---|---|---|
Generic Name | Text | |
Brand Name | Text | |
Strength (Format) | Text | |
Manufacturer | Text | |
Reason for Use | Text | |
CED Recommendation | Text | |
Date Reviewed | Text | |
Funding Status* (Effective Date) | Text |
Additional information
- Last updated
- December 6, 2023
- Created
- October 20, 2023
- Format
- application/csv
- File size
- 40 KiB
- Licence
- Open Government Licence – Ontario
- Name
- EO decisions and CED recommendations
- Type
- Data
- Language
- English
- Data made public date
- October 20, 2023
- Data range start
- January 13, 2016
- Data range end
- June 30, 2023
Help us improve the Data Catalogue
Provide feedback about our data and how you’re using it.